Electrodialysis Ion-Exchange Membrane Patent Landscape 2026 | Patsnap
- Activity peaked in 2024 at 126 families, then dropped sharply — a pattern suggesting that the field's latest growth wave has crested and consolidation is underway.
- Bipolar-membrane chemistry dominates citation influence, with the most-cited records clustering around composite solid polymer electrolyte membranes, signalling dense prior art exactly where new entrants most often aim.
- The US leads receiving offices by a wide margin, yet a strong China–EPO–Japan trio reflects genuinely global commercial interest and creates multi-jurisdiction freedom-to-operate complexity for any new programme.
Filing growth compares 2021 (46 records) with 2024 (126) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 2,019 records in scope (CR5), not by the ranked leaders only.
Electrodialysis membranes: the IP terrain at a glance
Electrodialysis (ED) separates ionic species by driving them through ion-exchange membranes under an applied electric field. The technology spans desalination, acid and base recovery, food-grade purification, and — increasingly — electrochemical synthesis. Three membrane architectures structure most of the claim space: cation-exchange membranes, anion-exchange membranes, and bipolar membranes (BPMs), which combine both layers to split water and generate acids and bases simultaneously without added reagents. BPM-based electrodialysis has attracted disproportionate research attention because it enables circular-chemistry routes — for instance, regenerating acids and bases from salt streams — that align with industrial decarbonisation targets. The corpus sits at the intersection of polymer science, electrochemistry, and separation engineering, which is why the IPC composition spans from B01D separation processes all the way to C12P fermentation applications.
Filing activity across the 2,019 families in this corpus grew steadily from 2017 through a 2024 peak, then fell back. Because patent applications are typically published 18 months after filing, the most recent year's count is structurally understated and should not be read as a signal of declining interest on its own. What is more telling is the mid-period: filings in 2022 sat at roughly half the 2024 peak, implying that the acceleration was relatively recent and concentrated. The broad separation-process class B01D accounts for the vast majority of records, while water-treatment (C02F) and electrolytic synthesis (C25B) form substantial secondary clusters — a distribution that reflects both the established desalination market and the emerging green-chemistry applications pulling investment into the field.
What the numbers say about momentum and geography
The filing trajectory and geographic spread of this corpus reveal where commercial expectations are highest and where prosecution strategies diverge. Neither trend tells the full story without the other: a jurisdiction preference signals where enforcement is expected, while the trend shape signals how confident filers are in near-term market return.
Filing trend: 2017–2026
Annual family counts rose from 39 in 2017 to a corpus peak of 126 in 2024 before pulling back in 2025–2026. The 2022 midpoint of 75 families sits almost exactly between the 2017 baseline and the 2024 high, indicating roughly linear growth through the middle of the period rather than a sudden surge. The most recent year's figure (14 published families as of the data cut-off) is structurally understated by publication lag and cannot be compared directly to earlier years. What matters strategically is the 2024 peak: it represents a cohort of filings that will define the claim landscape for the next decade of licensing and litigation.
Technology composition by IPC subclass
B01D separation processes dominate at 1,962 records — nearly the full corpus — confirming that examiners and filers alike classify this work primarily as a separation technology. C02F water treatment (712 records) and C25B electrolytic synthesis (313 records) form the two most significant secondary clusters. C07C acyclic compounds (273) and C08J polymer processing (250) reflect the membrane-material dimension of the field. The presence of C12P fermentation records (106) is notable: it marks the growing use of ED stacks in biorefinery and fermentation-acid recovery, a sub-area where the prior-art density is considerably lower than in the core desalination space.
Shares are the percentage of the 2,019 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Electrodialysis – Ion-Exchange Membrane with Eureka
This page is one run against one query. Ask Eureka your own question about electrodialysis – ion-exchange membrane and every answer comes back with the patent numbers behind it.
Try EurekaFoundational records shaping the claim landscape
Methods for producing or purifying onium hydroxides by means of electrodialysis
The methods prepare or purify onium hydroxides of nitrogen, sulfur, or phosphorus using an electrodialysis apparatus whose cell units each contain a bipolar membrane and an anion-selective membrane, with an additional bipolar or cation-selective membrane positioned on the anode side between the last anion-selective membrane and the anode. The architecture enables selective ion transport and pH control without exogenous reagents.Abstract condensed from the published specification. Patent number, assignee (BASF Aktiengesellschaft), and filing details are rendered from the dataset.


| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US6248469B1 | Composite solid polymer electrolyte membranes | 408 |
| 2 | US7550216B2 | Composite solid polymer electrolyte membranes | 366 |
| 3 | US6221225B1 | Apparatus and process for electrodialysis of salts | 196 |
| 4 | US4024043A | Single film, high performance bipolar membrane | 173 |
| 5 | US20020045085A1 | Composite solid polymer elecrolyte membranes | 162 |
| 6 | US5891328A | Membrane-frame for processes including electrodialysis | 133 |
| 7 | US20040055955A1 | Production of purified water and high value chemicals from salt water | 132 |
| 8 | US20110203929A1 | Recovery of lithium from aqueous solutions | 127 |
| 9 | JP2009269810A | Method for producing high-purity lithium hydroxide | 127 |
| 10 | US7083730B2 | Production of purified water and high value chemicals from salt water | 127 |
Citation counts within a searched corpus favour older records — a document cited 400 times has had years more opportunity to accumulate references than one filed in 2022. Treat these figures as influence signals, not current-importance rankings. The full table with patent numbers, assignees, and citation counts is rendered from the underlying dataset.
Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →Reading the signals: density, influence, and collaboration
Three lenses illuminate this corpus beyond a simple headcount: where citation weight is concentrated (influence), how collaboration is structured (co-assignment), and what the technology mix implies for freedom to operate. Each lens points to a different risk or opportunity.
Prior art is dense at the composite-membrane core
The most-cited records cluster around composite solid polymer electrolyte membranes, with the top record attracting 408 citations and the next four all exceeding 160. This density is a direct map of where claim space is most contested. New filers targeting composite BPM architecture face a thick prior-art thicket that constrains both claim breadth and freedom to operate.
Multi-jurisdiction prosecution is the norm, not the exception
The US leads receiving offices (413 records), but China (295), the EPO (278), and Japan (252) are each substantial. WIPO PCT filings (157) confirm that filers are actively preserving options across markets before committing to national-phase costs. A freedom-to-operate opinion that covers only one jurisdiction will miss material risk.
Industry–industry partnerships dominate co-filing
The strongest co-assignee relationship links POSCO Research Institute of Industrialscience (RIST) with POSCO Holdings at 19 jointly-assigned families — a company-internal pairing that signals coordinated IP strategy across a corporate group rather than external technology transfer. The Solvay–EDF pairing (17 families) represents a genuine cross-sector collaboration between a specialty-chemicals major and a utility, pointing to industrial-scale acid–base recovery as a shared commercial target.
Biorefinery is an emerging but under-patented application
The C12P fermentation sub-cluster (106 records) is large enough to be deliberate but small enough to contain genuine white space. ED membrane technology applied to organic-acid recovery from fermentation broths — lactic acid, succinic acid, itaconic acid — sits at the junction of biorefinery economics and membrane science. Citation density here is far lower than in the desalination core, making it a more navigable space for new entrants with application-specific claims.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to electrodialysis – ion-exchange membrane, with the prior art for and against each one.
| Assignee | Co-assignee | Shared families |
|---|---|---|
| POSCO Research Institute of Industrialscience (RIST) | POSCO Holdings Inc. | 19 |
| Solvay SA | Électricité de France SA (EDF) | 17 |
| Tokuyama Corporation | Daio Paper Corporation | 3 |
| Anixter International Inc. | ZHENG YONGCHANG | 3 |
| Anixter International Inc. | MACDONALD RUSSELL J | 3 |
| Anixter International Inc. | JU ALEX | 3 |
| POSCO Research Institute of Industrialscience (RIST) | POSCO (Pohang Iron and Steel Co., Ltd.) | 3 |
| Tokuyama Corporation | Snow Brand Meg Milk Co., Ltd. | 2 |
Ten co-assignee pairs are documented in the corpus. The POSCO group pairing (19 families) and the Solvay–EDF pairing (17 families) are the strongest. The Tokuyama–Daio Paper pairing (3 families) represents a smaller but industrially specific collaboration in paper-mill process chemistry. The network is sparse overall, indicating that most IP in this field is held and developed unilaterally — which in turn means fewer cross-licensing structures and potentially more aggressive enforcement postures.
Who holds position and where momentum has stalled
The assignee landscape is concentrated at the top — a small number of organisations account for a disproportionate share of families — followed by a long tail of single- or low-filing entrants. Recent-year momentum data tells a more sobering story: several of the historically active assignees recorded zero families in the latest available year, suggesting either portfolio maturation, strategic reorientation, or a shift toward trade-secret protection over patenting.
The top tier holds structural advantages
Organisations that built large portfolios through the growth phase of 2017–2024 now sit on estates that function as both defensive shields and licensing leverage. New entrants face the dual challenge of navigating existing claim scope and building enough of their own portfolio to achieve freedom to operate through cross-licensing.
Established players have paused — or pivoted
Multiple assignees that were active through 2023 recorded zero published families in the most recent year. Evoqua Water Technologies showed a -100% year-on-year change. This may reflect publication lag (filings from late 2024 not yet published), deliberate portfolio capping, or a strategic shift away from foundational claims toward trade-secret protection of process parameters.
Chemical-production majors compete alongside water specialists
The C25B electrolytic synthesis cluster (313 records) draws in chemical-production companies whose primary interest is not water treatment but acid–base or chlor-alkali synthesis. This cross-sector competition means that a water-treatment company's freedom to operate may be constrained by claims originally written for an entirely different end-use — a hazard that a technology-specific FTO search can easily miss.
| Assignee | Recent year | YoY |
|---|---|---|
| Tokuyama Corporation | 0 | — |
| Solvay SA | 0 | — |
| Anixter International Inc. | 0 | — |
| Evoqua Water Technologies LLC | 0 | -100% |
| Archer-Daniels-Midland Company (ADM) | 0 | — |
| Eka Chemicals AB | 0 | — |
| BASF SE | 0 | — |
| POSCO Research Institute of Industrialscience (RIST) | 0 | -100% |
From landscape to decision
A landscape analysis is the starting point, not the endpoint. The practical moves — claim mapping, FTO opinions, prosecution strategy, and competitive monitoring — all depend on going deeper than aggregate counts. These are the natural next steps for an R&D lead or IP counsel working in this space.
Map the claim scope of the highest-cited families
The composite solid polymer electrolyte membrane records at the top of the citation ranking set the outer boundary of what cannot be claimed without a licence or a successful challenge. A claim-level analysis of those families — not just the abstract — reveals exactly which structural features, process conditions, and application contexts are blocked, and where the gaps are.
Explore claim mapping in Patsnap Eureka →Run a cross-classification FTO search
Because this field spans B01D, C25B, C08J, and C07C, a single-class search will miss material risk. A properly scoped FTO opinion needs to track claims across all relevant subclasses and across the five major receiving offices identified in this corpus.
Start an FTO search in Patsnap Eureka →Monitor the zero-momentum assignees
Several historically active filers recorded no published families in the most recent year. This may be temporary — publication lag masks 2024–2025 filings — or it may signal a strategic shift. Setting up assignee-level monitoring alerts means you will know which interpretation is correct as soon as new publications appear.
Set up assignee monitoring in Patsnap Eureka →Identify prosecution opportunities in the fermentation sub-cluster
The C12P fermentation cluster (106 records) has substantially lower citation density than the desalination core. Application-specific claims tied to organic-acid selectivity, fermentation-broth pH profiles, or bioreactor-integrated ED configurations may face weaker prior art and therefore achieve broader allowable scope.
Analyse the fermentation sub-cluster in Patsnap Eureka →Practitioner questions about the electrodialysis ion-exchange membrane patent landscape
The corpus analysed here contains 2,019 patent families, searched across title, abstract, claims, and description using terms covering electrodialysis, electrodialysis reversal, ED stacks, ion-exchange membranes, bipolar membranes, and selective membranes, further filtered to IPC codes B01D61/44, B01D61/46, and C08J5/22. Patent families — rather than raw document counts — are the appropriate unit because they deduplicate continuation filings and multi-jurisdiction equivalents that would otherwise inflate the count. The 2,019-family figure therefore represents distinct inventive disclosures, not the total number of published documents in the space.
The assignee ranking is rendered from the underlying dataset and reflects family counts across the full 2015–2026 coverage window. The top tier is concentrated — a small group of organisations accounts for a disproportionate share of families — while a long tail of entrants holds one or two families each. Notably, several historically active assignees including Evoqua Water Technologies (Evoqua Water Technologies LLC) recorded zero published families in the most recent year, representing a -100% year-on-year change. Whether this reflects publication lag or deliberate portfolio capping is not determinable from the filing data alone and warrants continued monitoring.
A bipolar membrane (BPM) is a laminated structure comprising a cation-exchange layer and an anion-exchange layer joined at a catalytic interface. Under reverse-bias voltage, water molecules dissociate at the interface and the resulting protons and hydroxide ions migrate outward through their respective layers — effectively splitting water into acid and base without electrolysis gases or added reagents. This capability makes BPMs central to closed-loop acid–base recovery, CO₂ capture, and electrochemical synthesis, all of which are high-priority targets for industrial decarbonisation. The concentration of citation weight around composite solid polymer electrolyte membrane records reflects decades of foundational work on BPM architecture; these documents sit at the heart of the prior-art thicket that any new BPM-focused programme must navigate.
Several sub-areas show materially lower prior-art density relative to the desalination and chlor-alkali core. The fermentation-acid recovery space (mapped to IPC C12P, 106 records) is the clearest example: electrodialysis applied to recovering lactic, succinic, or itaconic acid from fermentation broths sits at the junction of biorefinery economics and membrane engineering, yet citation density is far lower than in the desalination mainstream. Other under-claimed areas include BPM-mediated separation of CO₂ electrolysis products, selective lithium-ion transport membranes for brine concentration, and surface-functionalised antifouling membranes using zwitterionic grafting. In each case, the opportunity lies in application-specific or material-specific claims that are not anticipated by the general polymer composition patents at the top of the citation ranking.
The corpus is genuinely global: the United States leads with 413 records, followed by China (295), the EPO (278), Japan (252), WIPO PCT (157), and Canada (104). This distribution means that a product commercialised in any major industrial market is likely to encounter granted patents in that jurisdiction. An FTO opinion scoped to a single country — typically the US — will structurally miss risk in China, Europe, and Japan, all of which have substantial claim coverage. WIPO PCT filings (157 records) indicate that many assignees are deliberately preserving multi-jurisdictional options before committing to national-phase prosecution, so the risk landscape will continue to expand as those applications enter national phase over the next several years.
Patent applications are typically published 18 months after their priority filing date, which means that filings made in late 2024 and throughout 2025 will not appear in a dataset with a mid-2026 cut-off. The most recent year's published count (14 families) is therefore a structural undercount, not evidence that filing activity has collapsed. The more meaningful signal is the 2024 peak of 126 families: that cohort of applications will shape the claim landscape for the next ten to fifteen years and represents the wave of prosecution activity currently underway at major offices. Analysts should treat the 2024 figure as the current high-water mark and revisit the trend once 2025 filings are fully published.
Yes, and they are easy to underestimate. The C25B electrolytic synthesis sub-cluster contains 313 records filed primarily by chemical-production and energy companies whose primary commercial interest is not water desalination but acid, base, or halogen production. Claims originally written for chlor-alkali or electrochemical synthesis contexts can read on ED membrane configurations used in water treatment or biorefinery applications, creating unexpected infringement exposure. The Solvay–EDF co-assignment pairing (17 jointly assigned families) is an example of exactly this cross-sector dynamic: a specialty-chemicals major and a utility building shared IP around industrial-scale acid–base recovery. Any FTO opinion in the ED membrane space should include a cross-classification search covering both B01D and C25B to capture this category of risk.
Ten co-assignee pairs are documented in the corpus, a relatively sparse network for a 2,019-family field. The two strongest pairings are the POSCO group internal pairing (POSCO Research Institute of Industrialscience with POSCO Holdings, 19 families) and the Solvay–EDF cross-sector pairing (17 families). The POSCO pairing represents coordinated intra-group IP strategy — the families are jointly assigned to channel both research and commercial rights within the corporate group. The Solvay–EDF pairing is more strategically revealing: it signals that at least two major European industrial organisations have already identified BPM-based acid–base recovery as a shared commercial target and have built a joint IP position around it. The overall sparseness of the co-assignee network suggests that most players in this field are prosecuting independently, which typically correlates with more aggressive enforcement postures and fewer pre-existing cross-licensing structures.
Research Electrodialysis – Ion-Exchange Membrane in depth with Eureka
Go past this page: query the whole electrodialysis – ion-exchange membrane corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.